Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should You Buy Moderna Before Feb. 13?


(NASDAQ: MRNA) has been on fire this year, with the biotech's shares up by 39% through Feb. 6. This isn't due to the company's financial results. Moderna has yet to release its fourth-quarter 2025 update. That's coming up on Feb. 13.

And although it provided guidance for 2025, that was months ago and wasn't nearly spectacular enough to jolt the stock this much. What's driving Moderna's performance in 2026? And should investors buy the stock before its next quarterly update? Let's take a look.

Image source: Getty Images.

Continue reading


Source Fool.com

Moderna Inc. Stock

€51.36
0.370%
The Moderna Inc. stock is trending slightly upwards today, with an increase of €0.19 (0.370%) compared to yesterday's price.
Currently there is a rather positive sentiment for Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
However, we have a potential of -59.11% for Moderna Inc. as the target price of 21 € is below the current price of 51.36 €.
Like: 0
Share

Comments